X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (76) 76
multiple sclerosis (51) 51
female (48) 48
male (47) 47
index medicus (44) 44
adult (43) 43
middle aged (39) 39
beer (35) 35
microbiology (35) 35
biochemistry (34) 34
chemistry (34) 34
compositions or test papers therefor (34) 34
condition-responsive control in microbiological orenzymological processes (34) 34
enzymology (34) 34
measuring or testing processes involving enzymes, nucleicacids or microorganisms (34) 34
metallurgy (34) 34
mutation or genetic engineering (34) 34
processes of preparing such compositions (34) 34
spirits (34) 34
vinegar (34) 34
wine (34) 34
neurosciences (32) 32
neurology (25) 25
clinical neurology (24) 24
immunology (22) 22
magnetic resonance imaging (20) 20
multiple sclerosis - genetics (19) 19
aged (17) 17
brain - pathology (15) 15
diagnostic-criteria (13) 13
disease (12) 12
finland (11) 11
analysis (10) 10
case-control studies (10) 10
genetic aspects (10) 10
disease progression (9) 9
expression (9) 9
genetics & heredity (9) 9
magnetic resonance imaging - methods (9) 9
medical colleges (9) 9
multiple sclerosis - immunology (9) 9
allergy and immunology (8) 8
apoptosis (8) 8
brain atrophy (8) 8
cerebrospinal-fluid (8) 8
genetic predisposition to disease (8) 8
genome-wide association study (8) 8
medicin och hälsovetenskap (8) 8
multiple sclerosis, relapsing-remitting - drug therapy (8) 8
radiology, nuclear medicine & medical imaging (8) 8
severity of illness index (8) 8
young adult (8) 8
brain (7) 7
central-nervous-system (7) 7
clinical trials (7) 7
follow-up studies (7) 7
genetics (7) 7
genotype (7) 7
medicine (7) 7
multiple sclerosis - pathology (7) 7
multiple-sclerosis (7) 7
research (7) 7
treatment outcome (7) 7
alleles (6) 6
association (6) 6
blood (6) 6
development and progression (6) 6
disability (6) 6
fi=neurologia ja psykiatria | en=neurology and psychiatry (6) 6
genes (6) 6
genetic research (6) 6
genome-wide association (6) 6
haplotypes (6) 6
hiv-1 (6) 6
interferon-beta - therapeutic use (6) 6
linkage disequilibrium (6) 6
medical and health sciences (6) 6
multiple sclerosis - blood (6) 6
multiple sclerosis - drug therapy (6) 6
polymorphism, single nucleotide - genetics (6) 6
research article (6) 6
susceptibility loci (6) 6
adolescent (5) 5
aged, 80 and over (5) 5
autoimmune diseases (5) 5
biological response modifiers (5) 5
biomarkers (5) 5
biomarkers - blood (5) 5
care and treatment (5) 5
cohort studies (5) 5
cytokines (5) 5
diffusion tensor imaging (5) 5
disability evaluation (5) 5
double-blind (5) 5
double-blind method (5) 5
drug therapy (5) 5
genetic predisposition to disease - genetics (5) 5
health aspects (5) 5
human-immunodeficiency-virus (5) 5
klinisk medicin (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Multiple Sclerosis Journal, ISSN 1352-4585, 3/2017, Volume 23, Issue 3, pp. 403 - 412
Journal Article
by Beecham, Ashley H and Patsopoulos, Nikolaos A and Xifara, Dionysia K and Davis, Mary F and Kemppinen, Anu and Cotsapas, Chris and Shah, Tejas S and Spencer, Chris and Booth, David and Goris, An and Oturai, Annette and Saarela, Janna and Fontaine, Bertrand and Hemmer, Bernhard and Martin, Claes and Zipp, Frauke and D'Alfonso, Sandra and Martinelli-Boneschi, Filippo and Taylor, Bruce and Harbo, Hanne F and Kockum, Ingrid and Hillert, Jan and Olsson, Tomas and Ban, Maria and Oksenberg, Jorge R and Hintzen, Rogier and Barcellos, Lisa F and Agliardi, Cristina and Alfredsson, Lars and Alizadeh, Mehdi and Anderson, Carl and Andrews, Robert and Søndergaard, Helle Bach and Baker, Amie and Band, Gavin and Baranzini, Sergio E and Barizzone, Nadia and Barrett, Jeffrey and Bellenguez, Céline and Bergamaschi, Laura and Bernardinelli, Luisa and Berthele, Achim and Biberacher, Viola and Binder, Thomas M.C and Blackburn, Hannah and Bomfim, Izaura L and Brambilla, Paola and Broadley, Simon and Brochet, Bruno and Brundin, Lou and Buck, Dorothea and Butzkueven, Helmut and Caillier, Stacy J and Camu, William and Carpentier, Wassila and Cavalla, Paola and Celius, Elisabeth G and Coman, Irène and Comi, Giancarlo and Corrado, Lucia and Cosemans, Leentje and Cournu-Rebeix, Isabelle and Cree, Bruce A.C and Cusi, Daniele and Damotte, Vincent and Defer, Gilles and Delgado, Silvia R and Deloukas, Panos and Di Sapio, Alessia and Dilthey, Alexander T and Donnelly, Peter and Dubois, Bénédicte and Duddy, Martin and Edkins, Sarah and Elovaara, Irina and Esposito, Federica and Evangelou, Nikos and Fiddes, Barnaby and Field, Judith and Franke, Andre and Freeman, Colin and Frohlich, Irene Y and Galimberti, Daniela and Gieger, Christian and Gourraud, Pierre-Antoine and Graetz, Christiane and Graham, Andrew and Grummel, Verena and Guaschino, Clara and Hadjixenofontos, Athena and Hakonarson, Hakon and Halfpenny, Christopher and Hall, Gillian and Hall, Per and Hamsten, Anders and Harley, James and Harrower, Timothy and Hawkins, Clive and Hellenthal, Garrett and Hillier, Charles and ... and Wellcome Trust Case Control Consor and Int IBD Genetics Consortium IIBDGC and International Multiple Sclerosis Genetics Consortium (IMSGC) and Wellcome Trust Case Control Consortium 2 (WTCCC2) and International IBD Genetics Consortium (IIBDGC) and Institutionen för fysik, kemi och biologi and Linköpings universitet and Bioinformatik and Tekniska högskolan
Nature Genetics, ISSN 1061-4036, 2013, Volume 45, Issue 11, pp. 1353 - 1362
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2009, Volume 8, Issue 6, pp. 519 - 529
Summary Background Treatment of relapsing-remitting multiple sclerosis with interferon beta is only partly effective, and new more effective and safe... 
Neurology | IV METHYLPREDNISOLONE | OUTCOME MEASURE | HIGH-DOSE METHYLPREDNISOLONE | AVONEX COMBINATION TRIAL | NEUTRALIZING ANTIBODIES | FUNCTIONAL COMPOSITE | ACUTE OPTIC NEURITIS | DOUBLE-BLIND | DIAGNOSTIC-CRITERIA | RESONANCE-IMAGING FINDINGS | CLINICAL NEUROLOGY | Confidence Intervals | Glucocorticoids - therapeutic use | Antibodies - metabolism | Follow-Up Studies | Methylprednisolone - therapeutic use | Humans | Middle Aged | Male | Psychomotor Performance - physiology | Interferon-beta - therapeutic use | Young Adult | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Adjuvants, Immunologic - therapeutic use | Disability Evaluation | Severity of Illness Index | Drug Administration Routes | Multiple Sclerosis, Relapsing-Remitting - immunology | Double-Blind Method | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Europe | Kaplan-Meier Estimate | Multiple Sclerosis, Relapsing-Remitting - physiopathology | Psychomotor Performance - drug effects | Interferon beta-1a | Adolescent | Multiple sclerosis | Corticosteroids | Interferon beta | Clinical trials | Universities and colleges | Drug therapy | Biological response modifiers | Methylprednisolone | Steroids | Computers | Sleep | beta -Interferon | Motivation | methylprednisolone | Bone mineral density | Interferon | Clinical Medicine | Neurologi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 12/2010, Volume 16, Issue 12, pp. 1437 - 1442
Background: Several studies show a high mortality risk among patients with multiple sclerosis (MS). Objectives: In this study, mortality and underlying causes... 
mortality | cause of death | female | multiple sclerosis | male | POPULATION | EPIDEMIOLOGIC SURVEY | PROGNOSTIC-FACTORS | LONG-TERM SURVIVAL | FOLLOW-UP | NATURAL-HISTORY | NEUROSCIENCES | CLINICAL NEUROLOGY | MODELS | DANISH PATIENTS | LIFE EXPECTANCY | Multiple Sclerosis - mortality | Humans | Age of Onset | Adult | Female | Male | Finland - epidemiology | Cause of Death | Death | Multiple sclerosis | Mortality | Influenza
Journal Article
by Baranzini, Sergio E and Khankhanian, Pouya and Patsopoulos, Nikolaos A and Li, Michael and Stankovich, Jim and Cotsapas, Chris and Søndergaard, Helle Bach and Ban, Maria and Barizzone, Nadia and Bergamaschi, Laura and Booth, David and Buck, Dorothea and Cavalla, Paola and Celius, Elisabeth G and Comabella, Manuel and Comi, Giancarlo and Compston, Alastair and Cournu-Rebeix, Isabelle and D’alfonso, Sandra and Damotte, Vincent and Din, Lennox and Dubois, Bénédicte and Elovaara, Irina and Esposito, Federica and Fontaine, Bertrand and Franke, Andre and Goris, An and Gourraud, Pierre-Antoine and Graetz, Christiane and Guerini, Franca R and Guillot-Noel, Léna and Hafler, David and Hakonarson, Hakon and Hall, Per and Hamsten, Anders and Harbo, Hanne F and Hemmer, Bernhard and Hillert, Jan and Kemppinen, Anu and Kockum, Ingrid and Koivisto, Keijo and Larsson, Malin and Lathrop, Mark and Leone, Maurizio and Lill, Christina M and Macciardi, Fabio and Martin, Roland and Martinelli, Vittorio and Martinelli-Boneschi, Filippo and McCauley, Jacob L and Myhr, Kjell-Morten and Naldi, Paola and Olsson, Tomas and Oturai, Annette and Pericak-Vance, Margaret A and Perla, Franco and Reunanen, Mauri and Saarela, Janna and Saker-Delye, Safa and Salvetti, Marco and Sellebjerg, Finn and Sørensen, Per Soelberg and Spurkland, Anne and Stewart, Graeme and Taylor, Bruce and Tienari, Pentti and Winkelmann, Juliane and Zipp, Frauke and Ivinson, Adrian J and Haines, Jonathan L and Sawcer, Stephen and DeJager, Philip and Hauser, Stephen L and Oksenberg, Jorge R and Wellcome Trust Case Control Consor and Int Multiple Sclerosis Genetics Co and International Multiple Sclerosis Genetics Consortium
The American Journal of Human Genetics, ISSN 0002-9297, 06/2013, Volume 92, Issue 6, pp. 854 - 865
Journal Article
Journal of Neuroimmunology, ISSN 0165-5728, 06/2019, Volume 331, p. 36
Multiple Sclerosis (MS) is an inflammatory neurodegenerative disease, where neural progenitor cell (NPC) transplantation has been suggested as a potential... 
Medical colleges | Nervous system diseases | Multiple sclerosis | Cytokines | Neurons | Analysis | Stem cells | Biological response modifiers | Cell differentiation
Journal Article
Journal Article
by Kapoor, Raju and Ho, Pei-Ran and Campbell, Nolan and Chang, Ih and Deykin, Aaron and Forrestal, Fiona and Lucas, Nisha and Yu, Bei and Arnold, Douglas L and Freedman, Steven and Freedman, Mark and Freedman, Mark S and Goldman, Myla D and Goldman, Myla and Hartung, Hans-Peter and Havrdová, Eva Kubala and Jeffery, Douglas and Miller, Tamara and Miller, Aaron and Sellebjerg, Finn and Cadavid, Diego and Mikol, Dan and Steiner, Deborah and Bartholomé, Emmanuel and D'Hooghe, Marie and Pandolfo, Massimo and Van Wijmeersch, Bart and Bhan, Virender and Blevins, Gregg and Brunet, Donald and Devonshire, Virginia and Duquette, Pierre and Grand'Maison, François and Jacques, François and Lapierre, Yves and Lee, Martin and Lee, Liesly and Morrow, Sarah and Yeung, Michael and Dufek, Michal and Kanovsky, Petr and Stetkarova, Ivana and Talabova, Marika and Frederiksen, Jette and Kant, Matthias and Petersen, Thor and Ravnborg, Mads and Airas, Laura and Elovaara, Irina and Eralinna, Juha-Pekka and Sarasoja, Taneli and Al Khedr, Abdullatif and Brassat, David and Brochet, Bruno and Camu, William and Debouverie, Marc and Laplaud, David and Lebrun Frenay, Christine and Pelletier, Jean and Vermersch, Patrick and Vukusi, Sandra and Baum, Karl and Berthele, Achim and Faiss, Juergen and Flachenecker, Peter and Hohlfeld, Reinhard and Krumbholz, Markus and Lassek, Christoph and Maeurer, Mathias and Meuth, Sven and Ziemssen, Tjalf and Hardiman, Orla and McGuigan, Christopher and Achiron, Anat and Karussis, Dimitrios and Bergamaschi, Roberto and Morra, Vincenzo Brescia and Comi, Giancarlo and Cottone, Salvatore and Grimaldi, Luigi and Mancardi, Giovanni Luigi and Massacesi, Luca and Nocentini, Ugo and Salvetti, Marco and Scarpini, Elio and Sola, Patrizia and Tedeschi, Gioacchino and Trojano, Maria and Zaffaroni, Mauro and Frequin, Stephan and Hupperts, Raymond and Killestein, Joep and Schrijver, Hans and Van Dijl, Ronald and van Munster, Erik and Czarnecki, Maciej and Drozdowski, Wieslaw and Fryze, Waldemar and Hertmanowska, Hanka and Ilkowski, Jan and ... and Investigators, A and ASCEND investigators
The Lancet Neurology, ISSN 1474-4422, 05/2018, Volume 17, Issue 5, pp. 405 - 415
Journal Article